Vaccine immunogen

Vaccine immunogens are the active biological components of vaccines designed to induce a specific and protective immune response against pathogens or diseased cells (CDC, 2023). These substances, which include proteins, polysaccharides, or nucleic acids (mRNA/DNA), act as antigens that are recognized by the host's immune system as foreign (NIH, 2024). Upon administration, immunogens are typically captured by antigen-presenting cells (APCs), such as dendritic cells, which process and present them to T-cells via Major Histocompatibility Complex (MHC) molecules (Janeway's Immunobiology, 2017). This interaction, often bolstered by adjuvants, triggers the activation and clonal expansion of antigen-specific B and T lymphocytes. The resulting production of high-affinity antibodies and the establishment of long-lived memory cells provide the basis for durable immunity (Nature Reviews Drug Discovery, 2021). While traditionally focused on infectious diseases, modern immunogen design is increasingly applied to therapeutic cancer vaccines and the management of chronic conditions.

Other names

AntigenVaccine antigenImmunogenic determinantEpitope-bearing molecule

Vaccine immunogens function by mimicking the molecular structure of pathogens to stimulate the adaptive immune system. They are recognized by B-cell receptors and processed by antigen-presenting cells for presentation to T-cells, leading to the generation of antigen-specific antibodies and memory cells (Janeway's Immunobiology, 2017; Nature Reviews Drug Discovery, 2021).